2022 ASAS/EULAR建议:中轴型脊柱炎的管理(更新版)

2022-10-21 国际评估强直性脊柱炎工作组 Ann Rheum Dis

2022年10月,国际评估强直性脊柱炎工作组(ASAS)联合欧洲抗风湿病联盟(EULAR)共同发布了中轴型脊柱炎的管理指南2022更新版。该建议主要针对中轴型脊柱炎的管理提出了5项总体原则和15项推荐

中文标题:

2022 ASAS/EULAR建议:中轴型脊柱炎的管理(更新版)

英文标题:

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

发布日期:

2022-10-21

简要介绍:

2022年10月,国际评估强直性脊柱炎工作组(ASAS)联合欧洲抗风湿病联盟(EULAR)共同发布了中轴型脊柱炎的管理指南2022更新版。该建议主要针对中轴型脊柱炎的管理提出了5项总体原则和15项推荐意见。

相关资料下载:
[AttachmentFileName(sort=1, fileName=ard-2022-223296.full.pdf)] GetToolGuiderByIdResponse(projectId=1, id=6df701c002e51a03, title=2022 ASAS/EULAR建议:中轴型脊柱炎的管理(更新版), enTitle=ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update, guiderFrom=Ann Rheum Dis, authorId=0, author=, summary=2022年10月,国际评估强直性脊柱炎工作组(ASAS)联合欧洲抗风湿病联盟(EULAR)共同发布了中轴型脊柱炎的管理指南2022更新版。该建议主要针对中轴型脊柱炎的管理提出了5项总体原则和15项推荐, cover=https://img.medsci.cn/Random/abdominal-pain-s4-photo-of-doctor-discussing-with-male-patient.jpg, journalId=0, articlesId=null, associationId=439, associationName=国际评估强直性脊柱炎工作组, associationIntro=The ASsessment in Ankylosing Spondylitis (ASAS) international Society is an international group of experts in the field of ankylosing spondylitis. The mission of ASAS is to support and promote the study of ankylosing spondylitis. * Increasing awareness and early diagnosis of the disease, * development and validation of assessment tools, and * the evaluation of treatment modalities in order to promote clinical research with the ultimate goal to improve outcome of the disease., copyright=0, guiderPublishedTime=Fri Oct 21 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p>2022年10月,国际评估强直性脊柱炎工作组(ASAS)联合欧洲抗风湿病联盟(EULAR)共同发布了中轴型脊柱炎的管理指南2022更新版。该建议主要针对中轴型脊柱炎的管理提出了5项总体原则和15项推荐意见。</p>, tagList=[TagDto(tagId=97561, tagName=中轴型脊柱炎)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=15, categoryName=风湿免疫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=971, appHits=42, showAppHits=0, pcHits=395, showPcHits=927, likes=0, shares=4, comments=0, approvalStatus=1, publishedTime=Mon Oct 24 15:22:09 CST 2022, publishedTimeString=2022-10-21, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Mon Oct 24 15:23:39 CST 2022, updatedBy=4754896, updatedName=侠胆医心, updatedTime=Sat Jan 06 13:59:13 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=ard-2022-223296.full.pdf)])
ard-2022-223296.full.pdf
下载请点击:
评论区 (0)
#插入话题